Trends in US Pediatric Asthma Hospitalizations, by Race and Ethnicity, 2012-2020

Sophie Binney1,2, W Dana Flanders3, Kanta Sircar4,5

  • 1Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee.

Preventing Chronic Disease
|September 19, 2024
PubMed

Insights

Pediatric asthma hospitalizations are decreasing across all racial groups, but disparities persist. Non-Hispanic Black children still experience the highest asthma burden, indicating a need for targeted interventions.

Area of Science:

  • Public Health
  • Epidemiology
  • Health Disparities

Background:

  • Racial and ethnic minority communities disproportionately experience higher asthma burdens.
  • Previous studies indicated stable or increasing pediatric asthma disparities.
  • Updated data analysis is crucial for understanding current trends in pediatric asthma disparities.

Purpose of the Study:

  • To analyze recent trends in pediatric asthma hospitalization disparities by race and ethnicity.
  • To assess changes in asthma hospitalization rates among different racial and ethnic groups from 2012 to 2020.
  • To determine if existing racial and ethnic disparities in pediatric asthma have changed over time.

Main Methods:

  • Utilized National Inpatient Sample data from 2012-2020 for pediatric asthma hospitalizations.
  • Calculated hospitalization rates using US Census Bureau data and performed meta-regression analysis.
  • Accounted for a 2015 diagnostic coding change by conducting separate analyses for pre- and post-change periods, excluding 2020 data from regression.

Main Results:

  • Pediatric asthma hospitalizations decreased overall during the study period.
  • Non-Hispanic Black children exhibited the highest prevalence of asthma hospitalizations (9.8-36.7 per 10,000 children).
  • Rates of decrease in asthma hospitalizations were similar across all racial and ethnic groups, suggesting persistent disparities.

Conclusions:

  • Non-Hispanic Black children continue to face a disproportionate burden of asthma-related hospitalizations.
  • While asthma hospitalization prevalence is declining universally, the similar rates of decline across groups indicate that disparities persist.
  • Targeted interventions addressing the specific needs of disproportionately affected groups are essential to reduce pediatric asthma disparities.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
364
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
227